Structure

Physi-Chem Properties

Molecular Weight:  542.12
Volume:  527.089
LogP:  3.852
LogD:  2.87
LogS:  -6.219
# Rotatable Bonds:  3
TPSA:  173.98
# H-Bond Aceptor:  10
# H-Bond Donor:  6
# Rings:  6
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.216
Synthetic Accessibility Score:  4.022
Fsp3:  0.133
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.971
MDCK Permeability:  6.151519301056396e-06
Pgp-inhibitor:  0.038
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.514
20% Bioavailability (F20%):  0.554
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.002
Plasma Protein Binding (PPB):  98.16097259521484%
Volume Distribution (VD):  0.493
Pgp-substrate:  2.827893018722534%

ADMET: Metabolism

CYP1A2-inhibitor:  0.409
CYP1A2-substrate:  0.089
CYP2C19-inhibitor:  0.825
CYP2C19-substrate:  0.044
CYP2C9-inhibitor:  0.851
CYP2C9-substrate:  0.972
CYP2D6-inhibitor:  0.306
CYP2D6-substrate:  0.518
CYP3A4-inhibitor:  0.882
CYP3A4-substrate:  0.104

ADMET: Excretion

Clearance (CL):  9.829
Half-life (T1/2):  0.476

ADMET: Toxicity

hERG Blockers:  0.084
Human Hepatotoxicity (H-HT):  0.16
Drug-inuced Liver Injury (DILI):  0.964
AMES Toxicity:  0.409
Rat Oral Acute Toxicity:  0.784
Maximum Recommended Daily Dose:  0.045
Skin Sensitization:  0.945
Carcinogencity:  0.11
Eye Corrosion:  0.003
Eye Irritation:  0.907
Respiratory Toxicity:  0.049

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC258474

Natural Product ID:  NPC258474
Common Name*:   Rel-Isochamaejasmin
IUPAC Name:   (2S,3R)-3-[(2R,3S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
Synonyms:  
Standard InCHIKey:  RNQBLQALVMHBKH-SQYWJIFTSA-N
Standard InCHI:  InChI=1S/C30H22O10/c31-15-5-1-13(2-6-15)29-25(27(37)23-19(35)9-17(33)11-21(23)39-29)26-28(38)24-20(36)10-18(34)12-22(24)40-30(26)14-3-7-16(32)8-4-14/h1-12,25-26,29-36H/t25-,26+,29+,30-
SMILES:  c1cc(ccc1[C@@H]1[C@@H]([C@@H]2C(=O)c3c(cc(cc3O[C@H]2c2ccc(cc2)O)O)O)C(=O)c2c(cc(cc2O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3318021
PubChem CID:   390361
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001586] Biflavonoids and polyflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. root n.a. PMID[15997133]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. root n.a. PMID[16141313]
NPO16205 Euphorbia fischeriana Species Euphorbiaceae Eukaryota roots n.a. n.a. PMID[16792421]
NPO16205 Euphorbia fischeriana Species Euphorbiaceae Eukaryota n.a. whole plant n.a. PMID[21534540]
NPO16205 Euphorbia fischeriana Species Euphorbiaceae Eukaryota whole plants Panshi, Jilin Province, China 2009-JUN PMID[21534540]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. callus n.a. PMID[22368856]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. PMID[23611151]
NPO299 Euphorbia ebracteolata Species Euphorbiaceae Eukaryota roots n.a. n.a. PMID[24660966]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota roots n.a. n.a. PMID[24931277]
NPO16205 Euphorbia fischeriana Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[25453801]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. PMID[26562066]
NPO16205 Euphorbia fischeriana Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[26702644]
NPO16205 Euphorbia fischeriana Species Euphorbiaceae Eukaryota Roots n.a. n.a. PMID[28383891]
NPO299 Euphorbia ebracteolata Species Euphorbiaceae Eukaryota Roots n.a. n.a. PMID[29148766]
NPO299 Euphorbia ebracteolata Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[31184480]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. root n.a. Database[Article]
NPO16205 Euphorbia fischeriana Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO299 Euphorbia ebracteolata Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16205 Euphorbia fischeriana Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO299 Euphorbia ebracteolata Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO16205 Euphorbia fischeriana Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO299 Euphorbia ebracteolata Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16205 Euphorbia fischeriana Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO299 Euphorbia ebracteolata Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 7300.0 nM PMID[518305]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC258474 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC201227
0.9932 High Similarity NPC309648
0.9932 High Similarity NPC198489
0.9932 High Similarity NPC61112
0.9866 High Similarity NPC287789
0.9866 High Similarity NPC271741
0.9799 High Similarity NPC69531
0.9667 High Similarity NPC32867
0.9603 High Similarity NPC475184
0.96 High Similarity NPC300668
0.96 High Similarity NPC134171
0.9539 High Similarity NPC295090
0.9474 High Similarity NPC1796
0.947 High Similarity NPC66441
0.947 High Similarity NPC182555
0.9467 High Similarity NPC174086
0.9419 High Similarity NPC63438
0.9412 High Similarity NPC51760
0.9412 High Similarity NPC51247
0.9404 High Similarity NPC121568
0.9351 High Similarity NPC98023
0.9351 High Similarity NPC226462
0.9351 High Similarity NPC42965
0.9346 High Similarity NPC257166
0.9329 High Similarity NPC122894
0.9299 High Similarity NPC224851
0.9295 High Similarity NPC38591
0.929 High Similarity NPC301256
0.929 High Similarity NPC312273
0.9286 High Similarity NPC15815
0.9286 High Similarity NPC105584
0.9267 High Similarity NPC3642
0.9257 High Similarity NPC311144
0.9236 High Similarity NPC473010
0.9231 High Similarity NPC473012
0.9231 High Similarity NPC473011
0.9226 High Similarity NPC195136
0.9221 High Similarity NPC318527
0.9221 High Similarity NPC323627
0.9221 High Similarity NPC324358
0.9221 High Similarity NPC322459
0.9216 High Similarity NPC79375
0.9216 High Similarity NPC37253
0.9211 High Similarity NPC39154
0.9211 High Similarity NPC78324
0.9211 High Similarity NPC208011
0.9211 High Similarity NPC115601
0.9195 High Similarity NPC299011
0.9189 High Similarity NPC113770
0.9177 High Similarity NPC171985
0.9177 High Similarity NPC320741
0.9172 High Similarity NPC473009
0.9161 High Similarity NPC123544
0.915 High Similarity NPC290830
0.915 High Similarity NPC72425
0.915 High Similarity NPC194593
0.915 High Similarity NPC71061
0.915 High Similarity NPC303485
0.9145 High Similarity NPC111112
0.9145 High Similarity NPC178484
0.9145 High Similarity NPC316960
0.9145 High Similarity NPC138299
0.9145 High Similarity NPC222713
0.9145 High Similarity NPC309512
0.9145 High Similarity NPC78835
0.9145 High Similarity NPC204561
0.9145 High Similarity NPC148945
0.9145 High Similarity NPC67322
0.9145 High Similarity NPC317715
0.9139 High Similarity NPC291746
0.9139 High Similarity NPC288840
0.9139 High Similarity NPC473016
0.9133 High Similarity NPC308200
0.9128 High Similarity NPC470136
0.9128 High Similarity NPC303185
0.9128 High Similarity NPC470135
0.9128 High Similarity NPC184649
0.9128 High Similarity NPC39045
0.9108 High Similarity NPC477841
0.9108 High Similarity NPC15374
0.9103 High Similarity NPC121647
0.9103 High Similarity NPC292863
0.9103 High Similarity NPC184326
0.9097 High Similarity NPC208258
0.9091 High Similarity NPC265624
0.9091 High Similarity NPC14606
0.9091 High Similarity NPC186227
0.9091 High Similarity NPC205026
0.9091 High Similarity NPC52611
0.9091 High Similarity NPC100049
0.9091 High Similarity NPC158027
0.9091 High Similarity NPC215203
0.9091 High Similarity NPC150908
0.9091 High Similarity NPC159707
0.9091 High Similarity NPC121649
0.9091 High Similarity NPC248739
0.9079 High Similarity NPC29777
0.9079 High Similarity NPC471115
0.9073 High Similarity NPC106328
0.9073 High Similarity NPC39195
0.9073 High Similarity NPC145467
0.9073 High Similarity NPC35150
0.9068 High Similarity NPC257667
0.9068 High Similarity NPC186847
0.9068 High Similarity NPC472454
0.9067 High Similarity NPC109183
0.9067 High Similarity NPC470133
0.9067 High Similarity NPC470134
0.9067 High Similarity NPC473078
0.9067 High Similarity NPC228779
0.9067 High Similarity NPC470131
0.9067 High Similarity NPC470132
0.9062 High Similarity NPC53252
0.9062 High Similarity NPC107627
0.9057 High Similarity NPC251336
0.9057 High Similarity NPC82330
0.9048 High Similarity NPC316480
0.9045 High Similarity NPC137232
0.9045 High Similarity NPC18380
0.9038 High Similarity NPC195167
0.9026 High Similarity NPC326592
0.9026 High Similarity NPC112701
0.9026 High Similarity NPC109594
0.9013 High Similarity NPC471114
0.9013 High Similarity NPC132345
0.9012 High Similarity NPC168789
0.9006 High Similarity NPC287884
0.9006 High Similarity NPC8704
0.9 High Similarity NPC271288
0.8994 High Similarity NPC477840
0.8993 High Similarity NPC202981
0.8987 High Similarity NPC219927
0.8986 High Similarity NPC110228
0.8986 High Similarity NPC76445
0.8986 High Similarity NPC284550
0.8986 High Similarity NPC6407
0.8986 High Similarity NPC188243
0.8986 High Similarity NPC129853
0.898 High Similarity NPC118813
0.8961 High Similarity NPC43345
0.894 High Similarity NPC472629
0.8933 High Similarity NPC107177
0.8933 High Similarity NPC81697
0.8933 High Similarity NPC223812
0.8933 High Similarity NPC278249
0.8933 High Similarity NPC85162
0.8933 High Similarity NPC125894
0.8933 High Similarity NPC77794
0.8931 High Similarity NPC290160
0.8924 High Similarity NPC97812
0.8924 High Similarity NPC114652
0.8924 High Similarity NPC175513
0.8919 High Similarity NPC225153
0.8919 High Similarity NPC310135
0.8919 High Similarity NPC20709
0.8919 High Similarity NPC140890
0.8919 High Similarity NPC329203
0.8919 High Similarity NPC222342
0.8919 High Similarity NPC150648
0.8919 High Similarity NPC265871
0.8919 High Similarity NPC274784
0.8919 High Similarity NPC261234
0.8917 High Similarity NPC308265
0.8912 High Similarity NPC296490
0.8912 High Similarity NPC79943
0.8912 High Similarity NPC12296
0.8912 High Similarity NPC13768
0.8912 High Similarity NPC32441
0.8912 High Similarity NPC295261
0.8912 High Similarity NPC243083
0.8912 High Similarity NPC287246
0.8912 High Similarity NPC107586
0.891 High Similarity NPC54830
0.891 High Similarity NPC56049
0.8903 High Similarity NPC203080
0.8903 High Similarity NPC244250
0.8903 High Similarity NPC20907
0.8903 High Similarity NPC324447
0.8896 High Similarity NPC312549
0.8896 High Similarity NPC476553
0.8896 High Similarity NPC477897
0.8896 High Similarity NPC209142
0.8896 High Similarity NPC476552
0.8896 High Similarity NPC289774
0.8896 High Similarity NPC209846
0.8896 High Similarity NPC328740
0.8896 High Similarity NPC476551
0.8882 High Similarity NPC296998
0.8882 High Similarity NPC475348
0.8882 High Similarity NPC10990
0.8882 High Similarity NPC473077
0.8882 High Similarity NPC300988
0.8882 High Similarity NPC261271
0.8875 High Similarity NPC474591
0.8874 High Similarity NPC124780
0.8874 High Similarity NPC470890
0.8874 High Similarity NPC235217
0.8874 High Similarity NPC473015
0.8874 High Similarity NPC473014
0.8874 High Similarity NPC131568

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC258474 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9091 High Similarity NPD8443 Clinical (unspecified phase)
0.9045 High Similarity NPD6959 Discontinued
0.8912 High Similarity NPD1552 Clinical (unspecified phase)
0.8912 High Similarity NPD1550 Clinical (unspecified phase)
0.8851 High Similarity NPD1549 Phase 2
0.8758 High Similarity NPD6167 Clinical (unspecified phase)
0.8758 High Similarity NPD6168 Clinical (unspecified phase)
0.8758 High Similarity NPD6166 Phase 2
0.8758 High Similarity NPD7852 Clinical (unspecified phase)
0.871 High Similarity NPD4380 Phase 2
0.8654 High Similarity NPD7411 Suspended
0.8627 High Similarity NPD7410 Clinical (unspecified phase)
0.8627 High Similarity NPD4378 Clinical (unspecified phase)
0.8616 High Similarity NPD4381 Clinical (unspecified phase)
0.8544 High Similarity NPD2393 Clinical (unspecified phase)
0.8523 High Similarity NPD1510 Phase 2
0.85 High Similarity NPD3749 Approved
0.8481 Intermediate Similarity NPD1934 Approved
0.8467 Intermediate Similarity NPD2796 Approved
0.8438 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8438 Intermediate Similarity NPD7768 Phase 2
0.8385 Intermediate Similarity NPD7075 Discontinued
0.8383 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8373 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD7074 Phase 3
0.8313 Intermediate Similarity NPD7819 Suspended
0.8282 Intermediate Similarity NPD5494 Approved
0.8263 Intermediate Similarity NPD7054 Approved
0.8255 Intermediate Similarity NPD1240 Approved
0.8214 Intermediate Similarity NPD7472 Approved
0.8205 Intermediate Similarity NPD1511 Approved
0.8199 Intermediate Similarity NPD2801 Approved
0.8199 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8166 Intermediate Similarity NPD6797 Phase 2
0.8146 Intermediate Similarity NPD1607 Approved
0.8144 Intermediate Similarity NPD7473 Discontinued
0.8129 Intermediate Similarity NPD3750 Approved
0.8118 Intermediate Similarity NPD7251 Discontinued
0.8108 Intermediate Similarity NPD4908 Phase 1
0.8101 Intermediate Similarity NPD1512 Approved
0.8095 Intermediate Similarity NPD3818 Discontinued
0.8072 Intermediate Similarity NPD6232 Discontinued
0.807 Intermediate Similarity NPD7808 Phase 3
0.8025 Intermediate Similarity NPD6801 Discontinued
0.8023 Intermediate Similarity NPD8312 Approved
0.8023 Intermediate Similarity NPD8313 Approved
0.8 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD3882 Suspended
0.7975 Intermediate Similarity NPD6799 Approved
0.7975 Intermediate Similarity NPD7390 Discontinued
0.7965 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7949 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7949 Intermediate Similarity NPD2800 Approved
0.7937 Intermediate Similarity NPD5403 Approved
0.7935 Intermediate Similarity NPD2344 Approved
0.7927 Intermediate Similarity NPD3817 Phase 2
0.7927 Intermediate Similarity NPD5402 Approved
0.7901 Intermediate Similarity NPD6599 Discontinued
0.7885 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7871 Intermediate Similarity NPD1551 Phase 2
0.7836 Intermediate Similarity NPD5844 Phase 1
0.7812 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD5401 Approved
0.7806 Intermediate Similarity NPD3748 Approved
0.7803 Intermediate Similarity NPD6559 Discontinued
0.7763 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD8455 Phase 2
0.7758 Intermediate Similarity NPD1465 Phase 2
0.7755 Intermediate Similarity NPD1610 Phase 2
0.7746 Intermediate Similarity NPD5953 Discontinued
0.7736 Intermediate Similarity NPD2309 Approved
0.773 Intermediate Similarity NPD3226 Approved
0.7709 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD2533 Approved
0.7702 Intermediate Similarity NPD2534 Approved
0.7702 Intermediate Similarity NPD2532 Approved
0.7692 Intermediate Similarity NPD2799 Discontinued
0.7677 Intermediate Similarity NPD6651 Approved
0.7674 Intermediate Similarity NPD3751 Discontinued
0.7673 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7657 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD3787 Discontinued
0.7643 Intermediate Similarity NPD6099 Approved
0.7643 Intermediate Similarity NPD6100 Approved
0.7635 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD4360 Phase 2
0.7624 Intermediate Similarity NPD4363 Phase 3
0.7607 Intermediate Similarity NPD920 Approved
0.7602 Intermediate Similarity NPD3926 Phase 2
0.7593 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD4628 Phase 3
0.7532 Intermediate Similarity NPD2313 Discontinued
0.7532 Intermediate Similarity NPD2935 Discontinued
0.7529 Intermediate Similarity NPD7286 Phase 2
0.7515 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4287 Approved
0.75 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7474 Intermediate Similarity NPD8151 Discontinued
0.7469 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD943 Approved
0.7434 Intermediate Similarity NPD1203 Approved
0.7425 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD6782 Approved
0.7419 Intermediate Similarity NPD6778 Approved
0.7419 Intermediate Similarity NPD6776 Approved
0.7419 Intermediate Similarity NPD6777 Approved
0.7419 Intermediate Similarity NPD6779 Approved
0.7419 Intermediate Similarity NPD3268 Approved
0.7419 Intermediate Similarity NPD6780 Approved
0.7419 Intermediate Similarity NPD6781 Approved
0.741 Intermediate Similarity NPD7458 Discontinued
0.7403 Intermediate Similarity NPD6832 Phase 2
0.7394 Intermediate Similarity NPD7698 Approved
0.7394 Intermediate Similarity NPD7696 Phase 3
0.7394 Intermediate Similarity NPD7697 Approved
0.7391 Intermediate Similarity NPD1243 Approved
0.7386 Intermediate Similarity NPD2798 Approved
0.7375 Intermediate Similarity NPD2346 Discontinued
0.7365 Intermediate Similarity NPD1548 Phase 1
0.7358 Intermediate Similarity NPD7033 Discontinued
0.7354 Intermediate Similarity NPD7870 Phase 2
0.7354 Intermediate Similarity NPD7871 Phase 2
0.7351 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD7003 Approved
0.7341 Intermediate Similarity NPD7229 Phase 3
0.7338 Intermediate Similarity NPD2861 Phase 2
0.7325 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD1613 Approved
0.732 Intermediate Similarity NPD2797 Approved
0.7312 Intermediate Similarity NPD5404 Approved
0.7312 Intermediate Similarity NPD5406 Approved
0.7312 Intermediate Similarity NPD5405 Approved
0.7312 Intermediate Similarity NPD5408 Approved
0.7308 Intermediate Similarity NPD3764 Approved
0.7302 Intermediate Similarity NPD7435 Discontinued
0.7296 Intermediate Similarity NPD7097 Phase 1
0.7289 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD7199 Phase 2
0.7278 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD5124 Phase 1
0.7273 Intermediate Similarity NPD7228 Approved
0.7273 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD5711 Approved
0.7241 Intermediate Similarity NPD5710 Approved
0.724 Intermediate Similarity NPD7701 Phase 2
0.7216 Intermediate Similarity NPD7783 Phase 2
0.7216 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD7213 Phase 3
0.7212 Intermediate Similarity NPD7212 Phase 2
0.7208 Intermediate Similarity NPD1470 Approved
0.7204 Intermediate Similarity NPD4361 Phase 2
0.7204 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD8150 Discontinued
0.7198 Intermediate Similarity NPD8434 Phase 2
0.7197 Intermediate Similarity NPD6798 Discontinued
0.7193 Intermediate Similarity NPD2296 Approved
0.7193 Intermediate Similarity NPD4288 Approved
0.7184 Intermediate Similarity NPD1247 Approved
0.7179 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD6844 Discontinued
0.7176 Intermediate Similarity NPD7577 Discontinued
0.7176 Intermediate Similarity NPD37 Approved
0.7169 Intermediate Similarity NPD7447 Phase 1
0.7168 Intermediate Similarity NPD6234 Discontinued
0.7151 Intermediate Similarity NPD4965 Approved
0.7151 Intermediate Similarity NPD6534 Approved
0.7151 Intermediate Similarity NPD6535 Approved
0.7151 Intermediate Similarity NPD4967 Phase 2
0.7151 Intermediate Similarity NPD4966 Approved
0.7143 Intermediate Similarity NPD3225 Approved
0.7143 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD5760 Phase 2
0.7135 Intermediate Similarity NPD5761 Phase 2
0.7128 Intermediate Similarity NPD7700 Phase 2
0.7128 Intermediate Similarity NPD7699 Phase 2
0.7128 Intermediate Similarity NPD7801 Approved
0.7126 Intermediate Similarity NPD6273 Approved
0.7124 Intermediate Similarity NPD9717 Approved
0.7124 Intermediate Similarity NPD1608 Approved
0.7115 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7098 Intermediate Similarity NPD7584 Approved
0.7097 Intermediate Similarity NPD3266 Approved
0.7097 Intermediate Similarity NPD3267 Approved
0.7083 Intermediate Similarity NPD8320 Phase 1
0.7083 Intermediate Similarity NPD8319 Approved
0.7079 Intermediate Similarity NPD7177 Discontinued
0.7079 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD4749 Approved
0.7077 Intermediate Similarity NPD7874 Approved
0.7077 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD6280 Approved
0.7076 Intermediate Similarity NPD6279 Approved
0.7073 Intermediate Similarity NPD2654 Approved
0.7069 Intermediate Similarity NPD919 Approved
0.7068 Intermediate Similarity NPD6823 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data